Boy, 2025 sure has been a whirlwind for savers. As we amble into the last quarter of the year, let's take a look at what 2025 ...
Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, ...
Continues momentum in pediatric innovation and platform developmentMINNEAPOLIS, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering ...